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Günter Blobel was a scientific colossus who dedicated his career to understanding the mechanisms for protein sorting to 
membrane organelles. His monumental contributions established research paradigms for major arenas of molecular cell 
biology. For this work, he received many accolades, including the Nobel Prize in Medicine or Physiology in 1999. He was a 
scientist of extreme passion and a nurturing mentor for generations of researchers, imbuing them with his deep love of cell 
biology and galvanizing them to continue his scientific legacy. Günter passed away on February 18, 2018, at the age of 81.
Günter was a Lebenskünstler—a master of the art of living. He 
had a tremendous presence; when he walked into a room, he 
couldn’t help but command attention. A towering man, with a 
flock of white hair and a jovial nature, he loved to tell stories: of 
experiences in the laboratory, of life in New York, and of his time 
growing up in Germany. Günter was born in 1936, as the son of 
a veterinarian. He considered his early childhood to be idyllic, 
raised with his seven siblings in a rural and remote part of Silesia, 
then in the eastern part of Germany. There, largely isolated from 
the horrific developments overtaking Europe, Günter recalled 
long afternoons in beautiful manor houses adorned with hunting 
trophies, winter days of sleighing, and summer days in horse-
drawn carriages. However, this life was shattered during the final 
months of the Second World War, when he and his family were 
forced to flee the advancing Soviet army. Passing through Dres-
den at this chaotic time, Günter experienced two life-changing 
events: seeing for the first time the magnificent baroque splen-
dor of this “great jewel of a city,” and days later, witnessing its 
leveling by Allied firebombing. The family picked up the threads 
of their former lives in Freiberg, a medieval town located to the 
west of Dresden. Again, Günter has fond recollections of his time 
there. He immersed himself in the town’s rich cultural legacy, 
centered around baroque and classical music performances in its 
Gothic cathedral. Unfortunately, the new communist regime of 
East Germany was inhospitable to the Blobel family, who were 
seen as part of the bourgeois class and were therefore denied 
access to higher education. Forced to leave Freiberg by these 
circumstances, Günter moved to Tübingen in West Germany to 
study medicine. Though he completed an MD degree, he was not 
inspired to become a practicing physician. Instead, he decided to 
try a career in research science.
Accordingly, Günter joined the laboratory of Van Potter at the 
University of Wisconsin to obtain a PhD. As a graduate student, he 
developed an interest in cell structure and function, and became 
engaged with a problem that subsequently became an obsession: 
how the cell sorts secretory proteins to the rough ER. To pursue 
these interests, he moved to the laboratory of George Palade at 
the Rockefeller University for postdoctoral studies. Günter’s time 
with Palade was a critical and formative experience, as the Palade 
laboratory was an intellectual epicenter for study of the ER. Pal-
ade and coworkers had described the secretory pathway during 
the 1960s in an exquisite series of studies that combined cell 
fractionation, biochemistry, and electron microscopy. Indeed, 
this and related work on the functions of membrane organelles 
earned Palade, Christian De Duve, and Albert Claude the Nobel 
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Prize in Medicine or Physiology in 1974. Günter revered Palade, 
and used his mentor’s work and conceptualization of cell func-
tion as a touchstone throughout his career.
As a newly promoted faculty member at the Rockefeller Uni-
versity, Günter set out to address the question of how mRNAs that 
encode secretory proteins are selected for synthesis on the rough 
ER. Despite a lack of experimental evidence, in 1971, Günter and 
David Sabatini proposed an amazingly prescient hypothesis (1). 
They suggested that ER targeting of secretory proteins is spec-
ified by the presence of a signal peptide on the N terminus of 
proteins destined to be translocated into the ER. This concept was 
subsequently termed the “signal hypothesis” (2). ‘‘At first it was 
just a wonderful idea,” Günter remembered; “It was quite a bold 
thing to say because nothing hinted at a signal sequence. But it 
was by far the best thing we could come up with.”
Inspired by his work with Palade, Günter knew that only a 
complete in vitro reconstitution of the ER translocation process 
with purified components—a Herculean challenge at the time—
could validate this hypothesis. Encouraged by studies from sev-
eral laboratories suggesting that the IgG light chain might be 
synthesized as a precursor polypeptide larger than the secreted 
form (1972–1975), he worked intensively to develop methods to 
biochemically dissect the process of ER secretory protein trans-
location. He provided the first strong experimental support for 
the signal hypothesis in two landmark papers in 1975 (2, 3). As 
with many of his most remarkable discoveries, these were pub-
lished in the Journal of Cell Biology. By analyzing IgG light chain 
synthesis using in vitro assays with isolated ER membranes, he 
obtained striking evidence for the presence of an N-terminal sig-
nal sequence on the nascent chains that was involved in cotrans-
lational translocation across the ER membrane, and that was 
cotranslationally removed (Fig. 1). He predicted that the signal 
sequence communicated with specific receptor proteins to medi-
ate ER attachment of ribosomes and induce transient assembly 
of a proteinaceous channel to conduct the nascent polypeptide 
across the ER membrane. He also proposed that the mechanisms 
and components involved in secretory protein translocation 
could be used for the insertion of membrane proteins into the 
ER. These ideas were controversial, particularly the notion that 
a proteinaceous channel was involved in signal sequence–medi-
ated membrane translocation, and became the focus of heated 
scientific debates for the subsequent two decades. But, as was 
typical of Günter’s outlook on science, he was unfazed: “I thought 
my ideas were reasonable. So why not propose them?”
Indeed, the controversies surrounding the signal hypothesis 
were laid to rest, one by one, by a series of elegant papers from the 
Blobel laboratory and from others over the next two decades. This 
work identified a cytosolic ribonucleoprotein particle (termed 
the SRP) that interacts with the signal sequence, a specific SRP 
receptor in the ER membrane involved in ribosome targeting, a 
signal peptidase that cotranslationally removes the signal pep-
tide, and, finally, the proteinaceous channel (Sec61 complex) that 
mediates movement of the nascent chain across the membrane 
(4). The evolutionary significance of signal-mediated protein 
translocation across the ER was resoundingly underscored by 
the identification of conserved systems in diverse organisms 
including yeast and bacteria. The experimental approach used by 
Günter and associates for these studies, involving the use of an in 
vitro assay with a quantitative functional output for mechanistic 
analysis by fractionation and reconstitution, helped usher in the 
era of modern molecular cell biology.
With the first experimental evidence for the signal hypothesis 
in hand, Günter prophetically speculated that systems analogous 
to those for ER translocation also might be deployed for targeting 
proteins to other membrane organelles (2). These speculations 
were decisively borne out in subsequent studies on protein trans-
port into the mitochondrion, the chloroplast, the peroxisome, 
and the nucleus (Fig. 2), providing the ultimate vindication for 
these bold conjectures. This was a major element of Günter’s 
principle of “protein topogenesis”: that information for sorting 
Figure 1. The original signal hypothesis 
(adapted from reference 2). (A) Illustration of 
the essential features of the signal hypothesis for 
the transfer of proteins across membranes. Sig-
nal codons after the initiation codon AUG are indi-
cated by a zigzag region in the mRNA. The signal 
sequence region of the nascent chain is indicated 
by a dashed line. Endoproteolytic removal of the 
signal sequence is indicated by the presence of 
signal peptides (indicated by short dashed lines). 
(B) Model for the formation of a transient pro-
teinaceous tunnel in the membrane through 
which the nascent chain is transferred.
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of proteins to different membrane compartments, as well as for 
integration into membranes, is encoded in discrete classes of 
“topogenic” sequences recognized by various receptor systems, 
membrane-spanning protein conduits, and other effectors (5).
Propelled by his polymathic character, Günter brought his 
enthusiasm and brilliance to bear on several other areas, particu-
larly nucleocytoplasmic transport and the nuclear lamina. In the 
mid-1970s, Günter and coworkers made the remarkable discov-
ery that nuclear pore complexes (NPCs) remain as intact struc-
tures after detergent extraction of nuclear envelopes, attached to 
a proteinaceous “nuclear lamina” derived from the inner surface 
of the nuclear envelope (Fig. 3, A and B; 6, 7). These results sug-
gested that NPCs could be isolated and biochemically analyzed, 
a goal that was realized many years later by trainees from his 
laboratory. Günter enthusiastically promoted the view that the 
nuclear lamina is a widespread nuclear structural component of 
fundamental importance, albeit not evident in most cells by elec-
tron microscopy. These results initiated a stream of biochemical 
and functional studies that gradually became an experimental 
torrent involving numerous laboratories. This effort has firmly 
established the importance of the lamina in myriad nuclear 
functions in higher eukaryotes, including nuclear mechanics, 
signaling, and the dynamic 3D functional organization of chro-
matin. The relatively recent discoveries linking mutations in 
nuclear lamina proteins to at least 15 human genetic disorders 
speak to Günter’s visionary intuition on the importance of the 
nuclear lamina.
In the arena of nucleocytoplasmic transport. Günter’s group 
was a frontrunner in the identification of nuclear transport fac-
tor proteins and NPC components, his competitive fervor help-
ing to propel the field forward at an astounding rate during the 
1990s. More recently, in keeping with his desire to understand 
the mechanistic principles of cells and fascinated by the molec-
ular architecture of these players, he retailored his laboratory 
to solve the atomic structures for some of the proteins compris-
ing these assemblies (Fig. 3 C). He drew great joy from solving 
molecular structures, seeing in them an elegance akin to that 
found in great architectural masterpieces, and he was adept in 
Figure 3. The nuclear envelope, and associated structures. (A and B) Transmission electron micrographs of a thin section through an NPC–lamina frac-
tion isolated from rodent liver, showing NPCs in lateral (single arrow) and frontal (double arrow) views, and the associated nuclear lamina (lA). Bars, 100 nm 
(adapted from reference 7). (C) An example of one of the most recent structures from the Blobel laboratory (PDB: 5SUP): the messenger ribonucleoprotein 
particles remodeling complex of Sub2 associated with an ATP analogue, RNA, and a C-terminal fragment of Yra1, required to process and package messenger 
ribonucleoprotein particles before export through the NPC.
Figure 2. The principles of protein targeting 
directed by signal sequences. A schematic of 
a cell is shown, with different membrane-bound 
organelles illustrated and labeled. Newly synthe-
sized proteins carry signal sequences, often but 
not always at one end of the protein, which can 
direct that protein to the correct organelle within 
the cell and allow them to cross the organellar 
membranes. The lower right inset depicts how 
additional classes of topogenic sequences (5) 
can specify the membrane integration of proteins 
(brown shading) instead of simple membrane 
translocation with signal sequence cleavage 
(orange shading).
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interpreting them in the context of cellular functions. Often he 
would retreat to his office for days, poring over stacks of litera-
ture and drawing on his experiences, to interpret their mecha-
nisms and dynamics, ultimately explaining them with flamboy-
ant imagery that reflected his love of cell biology.
Günter felt that doing science is a privilege and that it unifies 
humanity. He espoused da Vinci’s belief that “the noblest plea-
sure is the joy of understanding.” His enthusiasm was infectious 
and his laboratory was a hotbed of exciting ideas and around-
the-clock activity. Sometimes the exciting ideas did not survive 
rigorous experimental scrutiny. But Günter was not afraid to 
miss the mark. Those who knew him well also knew how passion-
ate he could become when a concept seemed particularly appeal-
ing. However, as he himself acknowledged, it sometimes became 
clear that (paraphrasing Thomas Huxley) “there are beautiful 
hypotheses killed by ugly facts.” He fully embraced this facet of 
scientific research, further stating that “one must not be wed to 
one’s fantasies.”
As trainees, it was a pleasure and privilege for us to be part of 
his life and to have been influenced by this extraordinary man. 
We started our careers on the fertile ground tilled by our time in 
Günter’s laboratory. He inspired us to think big and to ask the 
questions in biology that really mattered. Günter viewed his lab-
oratory as the greatest of master artists viewed their studios, just 
as these studios apprenticed new artists while the paintings were 
produced, Günter sought both to produce new scientific discov-
eries and to train new scientific researchers. Only last year, five 
of Günter’s postdoctoral researchers and senior fellows gained 
assistant professor tenure track positions. His office door was 
always open to his trainees, past and present. They knew they 
could go in, even if defeated and distraught after long strings of 
failures, thrash through the issues, work with him on new ways 
of tackling them, and emerge reinvigorated.
Günter’s passions extended beyond the scientific. The sim-
plest of things could ignite an exuberant outpouring. A walk 
with his dogs through Central Park, the flowers in the garden at 
the Rockefeller University, or an evening at his favorite haunt, 
Barbetta Restaurant. This sentiment and joie de vivre belied 
an intensely competitive spirit, but at heart Günter was a kind 
gentleman who was enormously generous. Spurred by his child-
hood experiences, he became the founder and president of the 
nonprofit organization Friends of Dresden. Indeed, he donated 
his Nobel Prize money to Dresden, devoted to the rebuilding of 
the Frauenkirche—a Lutheran church and baroque architectural 
masterpiece—and the New Synagogue, to replace the synagogue 
destroyed by the Nazis.
With deep sadness, we accept that eventually Günter grace-
fully succumbed to the self-described “noble injuries of time,” 
maintaining his enthusiasm until the end. There is so much 
more we could say about this incredibly inspiring man; we feel 
we got to know him well (Fig. 4). But, as Günter himself often 
liked to say, “less is more.” For his memorial, one can view the 
architectural splendors in Dresden reborn through his efforts, 
his towering masterpieces of scientific insight that underlie 
countless medical therapies and treatments being pioneered 
today, and the generations of researchers inspired by him who 
are continuing his work and who are passing on his baton to the 
next generations.
Figure 4. Blobel laboratory trainees were polled 
for up to five one-word descriptors they have used 
to describe Günter to their friends, family, and col-
leagues. Responses are shown in word cloud format 
produced using software from WordArt.com. The size of 
each word reflects its frequency of usage.
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